Minimal Change Disease

NEPTUNE Match Study

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)

taVNS for FRNS in Children

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Circulating Factors in Nephrotic Syndrome

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome

Diagnostic Value of Linked Color Imaging for Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and GERD